BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 30399364)

  • 1. Transgenic lysyl oxidase homolog 1 overexpression in the mouse eye results in the formation and release of protein aggregates.
    Zadravec P; Braunger BM; Melzer B; Kroeber M; Bösl MR; Jägle H; Schlötzer-Schrehardt U; Tamm ER
    Exp Eye Res; 2019 Feb; 179():115-124. PubMed ID: 30399364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of LOXL1 protein and Apolipoprotein E as components of surgically isolated pseudoexfoliation material by direct mass spectrometry.
    Sharma S; Chataway T; Burdon KP; Jonavicius L; Klebe S; Hewitt AW; Mills RA; Craig JE
    Exp Eye Res; 2009 Oct; 89(4):479-85. PubMed ID: 19442659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of lysyl oxidase-like 1 (LOXL1) and elastin-related genes by pathogenic factors associated with pseudoexfoliation syndrome.
    Zenkel M; Krysta A; Pasutto F; Juenemann A; Kruse FE; Schlötzer-Schrehardt U
    Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8488-95. PubMed ID: 21948647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotype-correlated expression of lysyl oxidase-like 1 in ocular tissues of patients with pseudoexfoliation syndrome/glaucoma and normal patients.
    Schlötzer-Schrehardt U; Pasutto F; Sommer P; Hornstra I; Kruse FE; Naumann GO; Reis A; Zenkel M
    Am J Pathol; 2008 Dec; 173(6):1724-35. PubMed ID: 18974306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical Profiles of LOXL-1, FBN1, TGF-β1, and COX-2 in Pseudoexfoliation Syndrome.
    Papadopoulou M; Papadaki H; Zolota V; Gartaganis SP
    Curr Eye Res; 2017 Jun; 42(6):880-889. PubMed ID: 28085506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression and properties of wild-type and Tyr437His mutated myocilin in the eyes of transgenic mice.
    Zillig M; Wurm A; Grehn FJ; Russell P; Tamm ER
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):223-34. PubMed ID: 15623777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of the blood-aqueous barrier and lens abnormalities in mice lacking lysyl oxidase-like 1 (LOXL1).
    Wiggs JL; Pawlyk B; Connolly E; Adamian M; Miller JW; Pasquale LR; Haddadin RI; Grosskreutz CL; Rhee DJ; Li T
    Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):856-64. PubMed ID: 24425853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and regulation of LOXL1 and elastin-related genes in eyes with exfoliation syndrome.
    Zenkel M; Schlötzer-Schrehardt U
    J Glaucoma; 2014; 23(8 Suppl 1):S48-50. PubMed ID: 25275906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic studies on the role of optineurin in the mouse eye.
    Kroeber M; Ohlmann A; Russell P; Tamm ER
    Exp Eye Res; 2006 Jun; 82(6):1075-85. PubMed ID: 16442524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posttranscriptional Regulation of LOXL1 Expression Via Alternative Splicing and Nonsense-Mediated mRNA Decay as an Adaptive Stress Response.
    Berner D; Zenkel M; Pasutto F; Hoja U; Liravi P; Gusek-Schneider GC; Kruse FE; Schödel J; Reis A; Schlötzer-Schrehardt U
    Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5930-5940. PubMed ID: 29164236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LOXL1 Hypermethylation in Pseudoexfoliation Syndrome in the Uighur Population.
    Ye H; Jiang Y; Jing Q; Li D; Maimaiti T; Kasimu D; Lu Y
    Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):5838-43. PubMed ID: 26348632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MALDI MS imaging analysis of apolipoprotein E and lysyl oxidase-like 1 in human lens capsules affected by pseudoexfoliation syndrome.
    Ronci M; Sharma S; Martin S; Craig JE; Voelcker NH
    J Proteomics; 2013 Apr; 82():27-34. PubMed ID: 23411028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of LOXL1 polymorphisms with pseudoexfoliation, glaucoma, intraocular pressure, and systemic diseases in a Greek population. The Thessaloniki eye study.
    Anastasopoulos E; Coleman AL; Wilson MR; Sinsheimer JS; Yu F; Katafigiotis S; Founti P; Salonikiou A; Pappas T; Koskosas A; Katopodi T; Lambropoulos A; Topouzis F
    Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4238-43. PubMed ID: 24917141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clusterin deficiency in eyes with pseudoexfoliation syndrome may be implicated in the aggregation and deposition of pseudoexfoliative material.
    Zenkel M; Kruse FE; Jünemann AG; Naumann GO; Schlötzer-Schrehardt U
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):1982-90. PubMed ID: 16639006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atomic force microscopy-based antibody recognition imaging of proteins in the pathological deposits in pseudoexfoliation syndrome.
    Creasey R; Sharma S; Gibson CT; Craig JE; Ebner A; Becker T; Hinterdorfer P; Voelcker NH
    Ultramicroscopy; 2011 Jul; 111(8):1055-61. PubMed ID: 21740868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological effect of LOXL1 coding variants associated with pseudoexfoliation syndrome.
    Sharma S; Martin S; Sykes MJ; Dave A; Hewitt AW; Burdon KP; Ronci M; Voelcker NH; Craig JE
    Exp Eye Res; 2016 May; 146():212-223. PubMed ID: 26997634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LOXL1 deficiency in the lamina cribrosa as candidate susceptibility factor for a pseudoexfoliation-specific risk of glaucoma.
    Schlötzer-Schrehardt U; Hammer CM; Krysta AW; Hofmann-Rummelt C; Pasutto F; Sasaki T; Kruse FE; Zenkel M
    Ophthalmology; 2012 Sep; 119(9):1832-43. PubMed ID: 22633114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on pseudoexfoliation syndrome pathogenesis and associations with intraocular pressure, glaucoma and systemic diseases.
    Anastasopoulos E; Founti P; Topouzis F
    Curr Opin Ophthalmol; 2015 Mar; 26(2):82-9. PubMed ID: 25594764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HNK-1 epitope in the lens-ciliary zonular region in normal and pseudoexfoliative eyes. Immunohistochemistry and ultrastructure.
    Qi Y; Streeten BW; Wallace RN
    Arch Ophthalmol; 1997 May; 115(5):637-44. PubMed ID: 9152132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compositional Analysis of Extracellular Aggregates in the Eyes of Patients With Exfoliation Syndrome and Exfoliation Glaucoma.
    De Maria A; Zientek KD; David LL; Wilmarth PA; Bhorade AM; Harocopos GJ; Huang AJW; Hong AR; Siegfried CJ; Tsai LM; Sheybani A; Bassnett S
    Invest Ophthalmol Vis Sci; 2021 Dec; 62(15):27. PubMed ID: 34964803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.